Citations

Clear

3485 citation(s) found for "Sy, Sarah".

Decreasing Delirium through Music (DDM) in Critically Ill, Mechanically Ventilated Older Adults in the Intensive Care Unit: A Two-Arm, Parallel-group, Randomized Clinical Trial
Seyffert, Sarah , Moiz, Salwa, Coghlan, M.A. , Balozian, Patil, Nasser, Jason , Rached, Emilio Abi, Naqvi, Kiran , Rawlings, Lori, Gao, Sujuan , Downs, H. Robert, Khan, Sikandar , Khan, Babar , Jamil, Yasser , Naqvi, Kiran, Perkins, Anthony J. , III, Hunter Downs, Heiderscheit, Annie , Chlan, Linda L.

Mayo Clinic

No container title available | May 11, 2022 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.21203/rs.3.rs-1033106/v1 Get It

Abstract Background: Delirium is a highly prevalent and morbid syndrome in mechanically ventilated intensive care unit (ICU) patients. Music is a promising non-pharmacological intervention with beneficial effects on anxiety and stress, while its effects on delirium duration and severity are not well understood.Methods/design: Our study is a two-arm, randomized parallel-group, clinical trial to evaluate the efficacy of music intervention compared to a silence-track attention control on delirium/coma duration in mechanically ventilated critically ill older adults. One-hundred-sixty mechanically ventilated adults 50 years of age or older will be randomized to one of two arms within 72 hours of ICU admission: (1) one-hour music listening sessions twice daily through noise-cancelling headphones, or (2) one-hour sessions of a silence track twice daily through noise-cancelling headphones. Our primary aim is to compare delirium/coma free days after randomization during the 7-day study intervention phase using the Confusion Assessment Method for the ICU (CAM ICU) and the Richmond Agitation Sedation Scale (RASS) for delirium and coma. Secondary outcomes include pain and anxiety evaluated twice daily during the intervention phase and throughout the duration of ICU stay using the Critical Care Pain Observation Tool (CPOT) and Visual Analogue Scale-Anxiety (VAS-A). Enrolled participants will be followed after hospital discharge to further measure cognition as well as screening for depression and anxiety using the following telephone-based instruments: Indiana University Telephone-Based Assessment of Neuropsychological Status (IU TBANS), Patient Health Questionnaire-9 (PHQ-9), and Generalized Anxiety Disorder-7 (GAD-7).Discussion: This randomized clinical trial will measure the efficacy of a music listening intervention for delirium and coma duration early in the intensive care unit among older adults.Trial Registration: https://clinicaltrials.gov/ct2/show/NCT04182334
Short- and Long-Term Biological Variability of Small Dense LDL, HDL3, and Triglyceride-Rich Lipoprotein Cholesterol
Fatica, Erica M. , Jenkins, Sarah M. , Scott, Renee, Block, Darci R , Meeusen, Jeffrey W. , Baumann, N, Saenger, Amy K., Scott, Renee’ J, Baumann, Nikola A, Donato, Leslie J.

Mayo Clinic

The Journal of Applied Laboratory Medicine | May 11, 2022 | Volume: 7 | Issue: 5 | Pages: 1047-1061

10.1093/jalm/jfac039 | PMID 35899495 Get It

Abstract Background Measurement of cholesterol within lipoprotein subfractions may aid in cardiovascular disease prediction. Simple, homogenous enzymatic assays for the direct measurement of lipoprotein subfractions have been developed to measure small dense low-density lipoprotein cholesterol (sdLDL-C), high-density lipoprotein-3 cholesterol (HDL3-C), and triglyceride-rich lipoprotein (TRL-C) cholesterol. The objective of this study was to determine biological variability for sdLDL-C, HDL3-C, and TRL-C in a healthy reference population to facilitate interpretation of these analytes. Methods Serum samples were collected from 24 healthy subjects (n = 14 female/10 male) daily for 3 days while non-fasting, and daily for 5 days, weekly for 4 weeks, and monthly for 6 months after overnight fasting. sdLDL-C, HDL3-C, and TRL-C cholesterol were measured by homogenous enzymatic assays. Sources of variability (between-subject, within-subject, and analytical) were calculated using random-effects regression models. Reference change value (RCV) and index of individuality (II) for each time period were determined from the variance components. Results Analytic variability (daily, weekly, and monthly CVA) was <3% for each analyte. Monthly within-subject variability (CVI) was 17.1% for sdLDL-C, 7.4% for HDL3-C, and 25.7% for TRL-C. Most of the monthly variation was attributed to between-subject variation for all 3 analytes. Overall RCVs for monthly measurements were 18.1 mg/dL for sdLDL-C, 6.1 mg/dL for HDL3-C, and 16.0 mg/dL for TRL-C. IIs were <0.6 for sdLDL-C and HDL3-C, and 0.81 for TRL-C. Conclusions sdLDL-C, HDL3-C, and TRL-C showed moderate within-subject variability, but high between-subject variability, in a healthy reference population. Given the high individuality of each analyte, population-based reference intervals may be inadequate to detect clinically significant changes.
CPI Emergency Imaging Module 2020
Brooks, Michael K., Choi, Andrew Y., Kubal, Wayne S., Mazzie, Joseph P., Menias, Christine A., Milla, Sarah Sarvis , Moshiri, Mariam , Nuñez, Diego , Raptis, Constantine A. , Roberts, Matthew S., Bhalla, Sanjeev , Cohen, Harris L. , Mellnick, Vincent M. , Patlas, Michael N.

Mayo Clinic

Continuous Professional Improvement | May 10, 2022 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.54057/cpi.er2020 Get It

Targeted temperature management after out of hospital cardiac arrest: quo vadis?
Hansen, Carolina Malta , Hassager, Christian , Jentzer, Jacob C. , Menon, Venu , Perman, Sarah M. , Diepen, Sean van , Granger, Christopher B. , Krychtiuk, Konstantin A , Jentzer, Jacob C , van Diepen, Sean , Granger, Christopher B , Hassager, Christian , Fordyce, Christopher B.

Mayo Clinic

European Heart Journal. Acute Cardiovascular Care | May 10, 2022 | Volume: 11 | Issue: 6 | Pages: 512-521

10.1093/ehjacc/zuac054 | PMID 35579006 Get It

AbstractTargeted temperature management (TTM) has become a cornerstone in the treatment of comatose post-cardiac arrest patients over the last two decades. Belief in the efficacy of this intervention for improving neurologically intact survival was based on two trials from 2002, one truly randomized-controlled and one small quasi-randomized trial, without clear confirmation of that finding. Subsequent large randomized trials reported no difference in outcomes between TTM at 33 vs. 36°C and no benefit of TTM at 33°C as compared with fever control alone. Given that these results may help shape post-cardiac arrest patient care, we sought to review the history and rationale as well as trial evidence for TTM, critically review the TTM2 trial, and highlight gaps in knowledge and research needs for the future. Finally, we provide contemporary guidance for the use of TTM in daily clinical practice.
A Nationwide Cross-Sectional Survey of Anesthesiology Fellowship Program Directors: Attitudes on Parental Leave in Residency and Fellowship Training
Malinzak, Elizabeth B. , Chandrabose, Rekha K. , Ku, Cindy, Hartlage, Sarah E. H., Hanson, Andrew C. , Schulte, Phillip J. , Sharpe, Emily E. , Malinzak, Elizabeth B , Sharpe, Emily E , Kraus, Molly B. , Pearson, Amy C. S.

Mayo Clinic

Women's Health Reports | May 8, 2022 | Volume: 3 | Issue: 1 | Pages: 395-404

10.1089/whr.2021.0130 | PMID 35652001 Get It

FC044: Heterozygous Variants in Kinase Domain of NEK8 cause an Autosomal-Dominant Ciliopathy
Claus, Laura R. , Stallworth, Jennifer L., Turner, Joshu, Hawks, Alexandra L. , May, Melanie , Louie, Raymond J. , Silver, Josh, Lerner-Ellise, Jordan, Morel, Chantal F. , Mighton, Chloe, Ziegler, Alban , Larsen, Martin J. , Lilien, Marc, Obeidová, Lena , Senum, Sarah R. , Rogers, Curtis , Duran, Karen, Peters, Edith, Senum, Sarah R , Jaarsveld, Richard H. van , Turner, Joshua L. , Flanagan‐Steet, Heather R. , Barakat, Tahsin Stefan , Dahan, Karin , Demoulin, Nathalie , Goffin, Eric Jean , Hertz, Jens Michael , Olinger, Eric , Sayer, John A , Seeman, Tomáš , Hanna, Christian , Harris, Peter C. , Mason, Jennifer M. , Haaften, Gijs W van , Eerde, Albertien M. van , Steet, Richard

Mayo Clinic

Nephrology Dialysis Transplantation | May 5, 2022 | Volume: 37 | Issue: Supplement_3 | Pages: No page available

10.1093/ndt/gfac104.004 Get It

Abstract BACKGROUND AND AIMS NEK8/NPHP9 encodes a protein that localizes to the primary cilium. Biallelic NEK8 variants are known to cause multiorgan developmental defects, including kidney cystic dysplasia and extensive extra-renal defects, with heterozygous carrier parents being asymptomatic [1]. This autosomal recessive inheritance is the most common inheritance mode for ciliopathies. Complementary to this, we now propose a dominant negative effect for specific heterozygous NEK8 missense variants in the kinase domain resulting in an autosomal-dominant ciliopathy. METHOD We performed genetic testing in patients from several medical centers. To explore the consequences of the identified NEK8 variants, we are performing cilia staining assays in patients' skin fibroblast and kidney cells, as well as in mIMCD3 cells overexpressing the identified variants. Furthermore, we are examining the impact of the NEK8 variants on replication stress response. RESULTS We identified three distinct heterozygous NEK8 variants in 12 families (Table 1), all leading to missense alterations in the kinase domain. Interestingly the p.Arg45Trp variant is a recurrent variant we detected in 10 unrelated families. All patients have a kidney phenotype that varies from mild focal segmental glomerulosclerosis to prenatal presentation with polycystic kidneys. Most patients have kidney failure needing kidney replacement therapy at varying ages of onset. In all patients, we thoroughly checked whether a second variant could be found. Furthermore, the large symptomatic family and de novo occurrences favor a dominant inheritance mode. Our preliminary results from functional studies show abnormal primary cilia formation in serum-starved cells as well as increased replication stress. CONCLUSION We present the first evidence for a pathogenic effect of heterozygous NEK8 variants. Remarkably our patients present with a kidney limited phenotype as compared to the multiorgan defects found in patients with biallelic variants. This reveals a new mode of inheritance for NEK8 variants and expands genotype-phenotype correlations for this gene.
Admission Serum Sodium and Osmolarity Are Not Associated with The Occurrence or Outcomes of Acute Respiratory Distress Syndrome in Critically Ill
Weister, Timothy J. , Chalmers, Sarah , Li, Heyi , Bihari, Shailesh , LeMahieu, Allison , Kashyap, Rahul , Lal, Amos , Bersten, Andrew D. , Gajic, Ognjen

Mayo Clinic

No container title available | May 5, 2022 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.21203/rs.3.rs-1614816/v1 Get It

Abstract ObjectivePrevious studies suggested that hypernatremia or hyperosmolarity may have protective effects in lung injury. We hypothesized that hypernatremia and/or hyperosmolarity would prevent ARDS in those at risk of lung injury and associated with favorable outcomes in ARDS patients.SubjectsAll admissions at medical, surgical, and multidisciplinary intensive care units in Mayo Clinic, Rochester from the year of 2009 to 2019.DesignRetrospective cohort study. The occurrence of ARDS was identified using a validated computerized search strategy. The association between serum sodium/osmolarity and the occurrence of ARDS was analyzed using a multivariable logistic regression model. The relationship between serum sodium/osmolarity and outcomes of ARDS was analyzed using linear and logistic regression models.ResultsAmong 50,498 patients, the serum sodium level on admission did not have a significant association with the occurrence of ARDS, with an adjusted odds ratio of 0.95 [95% CI (0.86, 1.05)]. There was no significant association between calculated serum osmolarity and the occurrence of ARDS, with an adjusted odds ratio of 1.03 [95% CI (1.00, 1.07)]. 1560 patients developed ARDS during the ICU stay. Their serum sodium level did not have a significant association with their outcomes [adjusted estimated difference in 28-day ICU-free days, 0.08 days, 95% CI (-0.85, 1.02), adjusted estimated difference in 28-day ventilator-free days, -0.02, 95% CI (-0.62, 0.58), adjusted odds ratio of 28-day mortality 1.02, 95%CI (0.84, 1.24)]. There was no significant association between their calculated serum osmolarity and their outcomes [adjusted estimated difference in 28-day ICU-free days, -0.26, 95% CI, (-0.63, 0.12); adjusted estimated difference in 28-day ventilator-free days, -0.05, 95% CI (-0.28, 0.19); adjusted odds ratio of 28-day mortality, 1.07, 95% CI (0.99, 1.15)].ConclusionsAdmission serum sodium or serum osmolarity were not associated with the occurrence or outcomes of ARDS in ICU.
Documentation of Psychosocial Distress and Its Antecedents in Children with Rare or Life-Limiting Chronic Conditions
McCarthy, Sarah , Golembiewski, Elizabeth H. , Gravholt, Derek L. , Clark, Jennifer , Clark, Jeannie, Fischer, Caree, Mulholland, Hannah , Babcock, Kristina, Jones, Amie E., McCarthy, Sarah R. , Clark, Jennifer E, McCarthy, Sarah R , Golembiewski, Elizabeth H , Clark, Jennifer E., Montori, Víctor M. , McCarthy, Sarah R.

Mayo Clinic

Children | May 5, 2022 | Volume: 9 | Issue: 5 | Pages: 664

10.3390/children9050664 | PMID 35626841 Get It

Children with rare or life-limiting chronic conditions and their families are at high risk of psychosocial distress. However, despite its impact on patient and family health and functioning, psychosocial distress and its antecedents may not routinely be captured in medical records. The purpose of this study was to characterize current medical record documentation practices around psychosocial distress among children with rare or life-limiting chronic conditions and their families. Medical records for patients with rare or life-limiting chronic conditions (n = 60) followed by a pediatric complex care program were reviewed. Study team members extracted both structured data elements (e.g., diagnoses, demographic information) and note narratives from the most recent visit with a clinician in the program. Psychosocial topics were analyzed using a mixed quantitative (i.e., frequency counts of topics) and qualitative approach. Topics related to psychosocial distress that were documented in notes included child and parent emotional problems, parent social support, sibling emotional or physical problems, family structure (e.g., whether parents were together), and financial concerns. However, 35% of notes lacked any mention of psychosocial concerns. Although examples of psychosocial concerns were included in some notes, none were present in over one-third of this sample. For both patients with rare or life-limiting chronic conditions and their caregivers, more active elicitation and standard documentation of psychosocial concerns may improve the ability of healthcare providers to identify and intervene on psychosocial concerns and their risk factors.
CD117, BAP1, MTAP, and TdT Is a Useful Immunohistochemical Panel to Distinguish Thymoma from Thymic Carcinoma
Angirekula, Mounika, Chang, Sindy Y, Jenkins, Sarah M. , Greipp, Patricia T. , Sukov, William R. , Marks, Randolph S., Olivier, Kenneth R. , Cassivi, Stephen D. , Roden, Anja C. , Greipp, Patricia T

Mayo Clinic

Cancers | May 5, 2022 | Volume: 14 | Issue: 9 | Pages: 2299

10.3390/cancers14092299 | PMID 35565429 Get It

Background: The morphologic distinction between thymic carcinomas and thymomas, specifically types B3, A, and occasionally micronodular thymomas with lymphoid stroma (MNTLS) can be challenging, as has also been shown in interobserver reproducibility studies. Since thymic carcinomas have a worse prognosis than thymomas, the diagnosis is important for patient management and treatment. This study aimed to identify a panel of immunohistochemical (IHC) markers that aid in the distinction between thymomas and thymic carcinomas in routine practice. Materials and Method: Thymic carcinomas, type A and B3 thymomas, and MNTLS were identified in an institutional database of thymic epithelial tumors (TET) (1963–2021). IHC was performed using antibodies against TdT, Glut-1, CD5, CD117, BAP1, and mTAP. Percent tumor cell staining was recorded (Glut-1, CD5, CD117); loss of expression (BAP1, mTAP) was considered if essentially all tumor cells were negative; TdT was recorded as thymocytes present or absent (including rare thymocytes). Results: 81 specimens included 44 thymomas (25 type A, 11 type B3, 8 MNTLS) and 37 thymic carcinomas (including 24 squamous cell carcinomas). Using BAP1, mTAP, CD117 (cut-off, 10%), and TdT, 88.9% of thymic carcinomas (95.7% of squamous cell carcinomas) and 77.8% of thymomas could be predicted. Glut-1 expression was not found to be useful in that distinction. All tumors that expressed CD5 in ≥50% of tumor cells also expressed CD117 in ≥10% of tumor cells. In four carcinomas with homozygous deletion of CDKN2A, mTAP expression was lost in two squamous cell carcinomas and in a subset of tumor cells of an adenocarcinoma and was preserved in a lymphoepithelial carcinoma. Conclusion: A panel of immunostains including BAP1, mTAP, CD117 (using a cut-off of 10% tumor cell expression), and TdT can be useful in the distinction between thymomas and thymic carcinomas, with only a minority of cases being inconclusive.
A review of the current status of lenalidomide maintenance therapy in multiple myeloma in 2022
Gupta, Ravi Kumar, Gupta, Ashish , Hillengaß, Jens , Holstein, Sarah A. , Suman, Vera J. , Taneja, Alankrita , McCarthy, Philip L.

Mayo Clinic

Expert Review of Anticancer Therapy | May 3, 2022 | Volume: 22 | Issue: 5 | Pages: 457-469

10.1080/14737140.2022.2069564 | PMID 35503516 Get It